Clinical Trials Browser

OTHER × Interventional × tezacitabine × Clear all

NCT00061620 2018-11-01

Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms